EMERYVILLE, Calif., May 31, 2016 (GLOBE NEWSWIRE) -- Zogenix, Inc. (NASDAQ:ZGNX), a pharmaceutical company developing therapies for the treatment of central nervous system (CNS) disorders, today announced that Stephen J. Farr, Ph.D., President and CEO, will present a corporate update at the Jefferies 2016 Healthcare Conference, which is being held in New York, NY, June 7-10, 2016.
|Jefferies 2016 Healthcare Conference -- Zogenix Presentation Details|
|Date:||Tuesday, June 7, 2016|
|Time:||9:30 am Eastern Time / 6:30 am Pacific Time|
|Location:||New York, NY|
The presentation will be webcast live and archived for 30 days on Zogenix's Investor Relations website at ir.zogenix.com.
Zogenix, Inc. (Nasdaq:ZGNX) is a pharmaceutical company committed to developing and commercializing CNS therapies that address specific clinical needs for people living with orphan and other CNS disorders who need innovative treatment alternatives to improve their daily functioning.
For more information, visit www.zogenix.com.
CONTACT: Investors: Andrew McDonald Founding Partner, LifeSci Advisors LLC 646-597-6987 | Andrew@lifesciadvisors.com